19andersonn (Talk | contribs) |
19andersonn (Talk | contribs) |
||
Line 2: | Line 2: | ||
{{ASIJ_Tokyo/CSS}} | {{ASIJ_Tokyo/CSS}} | ||
<html> | <html> | ||
+ | <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:ASIJ_Tokyo/CSS&action=raw&ctype=text/css" /> | ||
<style type="text/css"> | <style type="text/css"> | ||
Line 13: | Line 14: | ||
#background { | #background { | ||
− | background-image: url( | + | background-image: url(________); |
height: 580px; | height: 580px; | ||
background-position: center; | background-position: center; | ||
Line 23: | Line 24: | ||
#yajirushi { | #yajirushi { | ||
position: absolute; | position: absolute; | ||
− | bottom: | + | bottom: 65px; |
z-index: 1; | z-index: 1; | ||
width: 100px; | width: 100px; | ||
height: 30px; | height: 30px; | ||
− | left: | + | left: 50%; |
} | } | ||
− | # | + | #yuzuru { |
padding-top: 28px; | padding-top: 28px; | ||
} | } | ||
Line 39: | Line 40: | ||
} | } | ||
+ | li { | ||
+ | list-style-type: none; | ||
+ | } | ||
+ | |||
+ | #everything { | ||
+ | margin-left: 2%; | ||
+ | margin-top: 2% | ||
+ | } | ||
+ | |||
+ | h4 { | ||
+ | margin-top: 0; | ||
+ | margin-bottom: 0 | ||
+ | } | ||
#click { | #click { | ||
position: absolute; | position: absolute; | ||
Line 46: | Line 60: | ||
left: 45%; | left: 45%; | ||
} | } | ||
− | |||
− | |||
− | |||
</style> | </style> | ||
<body> | <body> | ||
<div id="background"> | <div id="background"> | ||
<div id="yajirushi"> | <div id="yajirushi"> | ||
− | <a href="# | + | <a href="#header"> |
− | <img src="https://static.igem.org/mediawiki/2018/6/6a/T--ASIJ_Tokyo--downarrow.png" height=" | + | <img src="https://static.igem.org/mediawiki/2018/6/6a/T--ASIJ_Tokyo--downarrow.png" height="120px"> |
</a> | </a> | ||
</div> | </div> | ||
Line 60: | Line 71: | ||
</div> | </div> | ||
<div id="wrapper"> | <div id="wrapper"> | ||
− | + | <h1 id="header"> EXPERIMENTS </h1> | |
− | + | <hr id="divider"> | |
− | + | <div id="everything"> | |
+ | <h4><a href="https://static.igem.org/mediawiki/2018/c/cc/T--ASIJ_Tokyo--crisprpart1.pdf" target="none">Part I CRISPR</a></h3> | ||
+ | <br> <h4><a href="https://static.igem.org/mediawiki/2018/3/30/T--ASIJ_Tokyo--crisprpart2.pdf">Part II CRISPR Confirmation (genotypic)</a></h3> | ||
+ | |||
+ | <br><h4>Part III: Designing of the new constructs (this is just modeling the construct design and not really a protocol)</h3> | ||
+ | <br> <h4><a href="https://static.igem.org/mediawiki/2018/f/fd/T--ASIJ_Tokyo--gibson.pdf">Part IV: Gibson Assembly of Constructs</a></h3> | ||
+ | <br> <h4>Part V: Deciding which fluorescent marker to use (water melon tubes, and plates)..deciding then to only use the GFP ones</h3> | ||
+ | <br> <h4>Part VI: Genotypic and Phenotypic Proof of Concept</h3> | ||
+ | <ul> | ||
+ | <li>a. Agarose gel electrophoresis of plasmid constructs (agarose gel electorphoresis protocol)</li> | ||
+ | <li>b. Phenotypic Proof (Transformation and growing on selection plates)</li> | ||
+ | </ul> | ||
+ | <h4>Part VII: Quantifying Protein</h3> | ||
+ | <ul> | ||
+ | <li>a. <a href="https://static.igem.org/mediawiki/2018/a/a7/T--ASIJ_Tokyo--oggfp.pdf">GFP protein purification using column chromatography</a></li> | ||
+ | <li>b. <a href="https://static.igem.org/mediawiki/2018/5/56/T--ASIJ_Tokyo--ogsialic.pdf">Sialic Acid Assay - original version of protocol </a></li> | ||
+ | </ul> | ||
+ | <h4>Part VIII: Incorporation of New information to use His-tag</h3> | ||
+ | <ul> | ||
+ | <li>a. Redesign construct to include His-tag</li> | ||
+ | <li>b. Gibson assembly </li> | ||
+ | <li>c. Transformation </li> | ||
+ | <li>d. <a href="https://static.igem.org/mediawiki/2018/2/2b/T--ASIJ_Tokyo--histag.pdf">Protein Purification using His Tag Protein Chromatography - | ||
+ | redone Oct 10 (10 trials)</a></li> | ||
+ | <li>c. <a href="https://static.igem.org/mediawiki/2018/8/84/T--ASIJ_Tokyo--esla.pdf">Sialic Acid Purification redone using new protocol (6 trials) </a></li> | ||
+ | <li>d. Fluoroscence Microplate Reading to Quantify Protein Concentration of Constructs | ||
+ | using GFP standard curve </li> | ||
+ | <li>e. Fluorescence Microplate Reading to Quantify Sialic Acid Concentration | ||
+ | using Sialic Acid Standard Curve </li> | ||
+ | <li>f. <a href="https://static.igem.org/mediawiki/2018/4/44/T--ASIJ_Tokyo--electro.pdf">Final Polyacrylamide Gel Confirmation of Constructs </a></li> | ||
+ | </ul> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
{{ASIJ_Tokyo/footer}} | {{ASIJ_Tokyo/footer}} |
Revision as of 15:02, 14 October 2018
EXPERIMENTS
Part I CRISPR
Part II CRISPR Confirmation (genotypic)
Part III: Designing of the new constructs (this is just modeling the construct design and not really a protocol)
Part IV: Gibson Assembly of Constructs
Part V: Deciding which fluorescent marker to use (water melon tubes, and plates)..deciding then to only use the GFP ones
Part VI: Genotypic and Phenotypic Proof of Concept
- a. Agarose gel electrophoresis of plasmid constructs (agarose gel electorphoresis protocol)
- b. Phenotypic Proof (Transformation and growing on selection plates)
Part VII: Quantifying Protein
- a. GFP protein purification using column chromatography
- b. Sialic Acid Assay - original version of protocol
Part VIII: Incorporation of New information to use His-tag
- a. Redesign construct to include His-tag
- b. Gibson assembly
- c. Transformation
- d. Protein Purification using His Tag Protein Chromatography -
redone Oct 10 (10 trials)
- c. Sialic Acid Purification redone using new protocol (6 trials)
- d. Fluoroscence Microplate Reading to Quantify Protein Concentration of Constructs
using GFP standard curve
- e. Fluorescence Microplate Reading to Quantify Sialic Acid Concentration
using Sialic Acid Standard Curve
- f. Final Polyacrylamide Gel Confirmation of Constructs
Part III: Designing of the new constructs (this is just modeling the construct design and not really a protocol)
Part IV: Gibson Assembly of Constructs
Part V: Deciding which fluorescent marker to use (water melon tubes, and plates)..deciding then to only use the GFP ones
Part VI: Genotypic and Phenotypic Proof of Concept
- a. Agarose gel electrophoresis of plasmid constructs (agarose gel electorphoresis protocol)
- b. Phenotypic Proof (Transformation and growing on selection plates)
Part VII: Quantifying Protein
- a. GFP protein purification using column chromatography
- b. Sialic Acid Assay - original version of protocol
Part VIII: Incorporation of New information to use His-tag
- a. Redesign construct to include His-tag
- b. Gibson assembly
- c. Transformation
- d. Protein Purification using His Tag Protein Chromatography -
redone Oct 10 (10 trials)
- c. Sialic Acid Purification redone using new protocol (6 trials)
- d. Fluoroscence Microplate Reading to Quantify Protein Concentration of Constructs
using GFP standard curve
- e. Fluorescence Microplate Reading to Quantify Sialic Acid Concentration
using Sialic Acid Standard Curve
- f. Final Polyacrylamide Gel Confirmation of Constructs
Part V: Deciding which fluorescent marker to use (water melon tubes, and plates)..deciding then to only use the GFP ones
Part VI: Genotypic and Phenotypic Proof of Concept
- a. Agarose gel electrophoresis of plasmid constructs (agarose gel electorphoresis protocol)
- b. Phenotypic Proof (Transformation and growing on selection plates)
Part VII: Quantifying Protein
- a. GFP protein purification using column chromatography
- b. Sialic Acid Assay - original version of protocol
Part VIII: Incorporation of New information to use His-tag
- a. Redesign construct to include His-tag
- b. Gibson assembly
- c. Transformation
- d. Protein Purification using His Tag Protein Chromatography -
redone Oct 10 (10 trials)
- c. Sialic Acid Purification redone using new protocol (6 trials)
- d. Fluoroscence Microplate Reading to Quantify Protein Concentration of Constructs
using GFP standard curve
- e. Fluorescence Microplate Reading to Quantify Sialic Acid Concentration
using Sialic Acid Standard Curve
- f. Final Polyacrylamide Gel Confirmation of Constructs
- a. Agarose gel electrophoresis of plasmid constructs (agarose gel electorphoresis protocol)
- b. Phenotypic Proof (Transformation and growing on selection plates)
Part VII: Quantifying Protein
- a. GFP protein purification using column chromatography
- b. Sialic Acid Assay - original version of protocol
Part VIII: Incorporation of New information to use His-tag
- a. Redesign construct to include His-tag
- b. Gibson assembly
- c. Transformation
- d. Protein Purification using His Tag Protein Chromatography -
redone Oct 10 (10 trials)
- c. Sialic Acid Purification redone using new protocol (6 trials)
- d. Fluoroscence Microplate Reading to Quantify Protein Concentration of Constructs
using GFP standard curve
- e. Fluorescence Microplate Reading to Quantify Sialic Acid Concentration
using Sialic Acid Standard Curve
- f. Final Polyacrylamide Gel Confirmation of Constructs
- a. Redesign construct to include His-tag
- b. Gibson assembly
- c. Transformation
- d. Protein Purification using His Tag Protein Chromatography - redone Oct 10 (10 trials)
- c. Sialic Acid Purification redone using new protocol (6 trials)
- d. Fluoroscence Microplate Reading to Quantify Protein Concentration of Constructs using GFP standard curve
- e. Fluorescence Microplate Reading to Quantify Sialic Acid Concentration using Sialic Acid Standard Curve
- f. Final Polyacrylamide Gel Confirmation of Constructs